Schizophrenia, Schizoaffective, and Bipolar Disorders share common illness traits, intermediate phenotypes and a partially overlapping polygenic basis. We performed GWAS on deep phenotyping data, including structural MRI and DTI, clinical, and behavioral scales from 1,115 cases and controls. Significant associations were observed with two cerebrospinal fluid volumes: the temporal horn of left lateral ventricle was associated with NRXN1, and the volume of the cavum septum pellucidum was associated with LRP1B and RORA. Both volumes were associated with illness. Suggestive associations were observed with local gyrification indices, fractional anisotropy and age at onset. The deep phenotyping approach allowed unexpected genetic sharing to be found between phenotypes, including temporal horn of left lateral ventricle and age at onset.
The NIMH Research Domain Criteria (RDoC) initiative (https://www.nimh.nih.gov/researchpriorities/rdoc/index.shtml) [6] conceives of dimensional traits that are continuous between patients and controls, and which can serve as a basis for revised definitions of disease traits and categories. In other medical disorders, such as hypertension, genetic variants have been associated with a related quantitative trait (blood pressure), once sample sizes were large enough to detect them [7] . Heritable variance in blood pressure and clinical hypertension are accounted for by GWAS-significant associations with common variants, by polygenic risk, and by rare variants with strong effect [8] , which is generally true for common diseases [9] .
There is ample evidence of partially overlapping brain morphology abnormalities in schizophrenia (SZ) and bipolar disorder (BD) [10] [11] [12] . These disorders also have a shared set of specific genetic loci associated with them, and a partially shared polygenic diathesis [1, 13] , as well as shared behavioral features including psychosis in some BD patients. Identifying genetic factors associated with specific biological traits associated with psychosis in these disorders can help to elucidate the biology of shared disease features, which may lead to improved disease classification and personalized treatment [14] .
Previous studies have identified enlargement of the ventricular system associated with bipolar disorder and schizophrenia [15, 16] . The temporal (inferior) horn of the left lateral ventricle and the cavum septum pellucidum (CSP) are two structures that have consistently been found enlarged in patients with these disorders [17] [18] [19] . In this study we found common variants of genes Neurexin1 (NRXN1), LDL receptor related protein 1B (LRP1B), and RAR-Related Orphan Receptor (RORA) associated with enlargement of these structures. A previous study by Rujescu et al. described rare structural genetic variants of NRXN1 associated with Schizophrenia [20] . NRXN1 encodes a large presynaptic transmembrane protein that binds neuroligins to calcium-dependent synaptic complexes in the central nervous system, and is also involved in the formation of synaptic contacts [21] . LRP1B is a candidate gene for Alzheimer's disease [22] and RORA is a candidate gene for PTSD [23] . coding RNA. Four other LGI suggestive associations pointed to other intergenic regions with P<1E-08 ( Table 1) . Analysis of variance did not show significant differences between cases and controls or among diagnostic categories for these phenotypes.
Associations with Fractional Anisotropy:
Fractional Anisotropy (FA) is a metric of white matter fiber density and integrity, computed from Diffusion Tensor Imaging (DTI). FA of the left external capsule was suggestively associated (P=2.947E-09) with rs143413095, an intergenic SNP on Chr.9p23.3; and FA of the left cerebral peduncle had suggestively significant association (P=4.233E-09) with rs819605, an intergenic SNP on Chr.1p21.3. No significant differences between cases and controls were observed for these two variables.
Association with Age at Onset:
One clinical phenotype, the "Age of first symptoms of schizophrenia or bipolar disorder" reached suggestive significance association with rs1377950 (P=6.841E-09), however this did not pass the FWER significance threshold for psychiatric and medical history variables (Supplementary Table 1 ). This SNP is an intergenic marker on Chr.2p16.2, 300Kb from LOC730100, a long non-coding RNA neighbor of the NRXN1 gene. A microRNA (Mir4431) has also been described adjacent to this locus. The CSP volume had a small but significant negative correlation with the age at onset in our sample (R= -0.118; P=3.89E-04).
Discussion:

Significant genetic associations with brain CSF volumetric variants related to psychotic disorders:
Cerebrospinal fluid volumes are some of the most reliable measurements captured with in vivo MRI, because of the high contrast between CSF and cerebral structures. Enlarged ventricular volumes have been among the most enduring anatomical findings in SZ and BD, first reported by Johnstone in schizophrenia forty years ago [27] . This has been confirmed in SZ and BD patients compared with healthy controls in large studies by the ENIGMA consortium [16, 28] , and its heritability calculated as 0.54 [29] . Increased ventricular volumes observed in schizophrenia have been attributed to volume reduction of surrounding grey matter structures [30, 31] . The temporal horn of the lateral ventricle traverses the temporal lobe and is in direct relation with the amygdala, hippocampus, and caudate nucleus. However, our GWAS on these structures' separate volumes did not have significant associations, which implies that the volumetric association may reflect joint regulation of part of the morphology of these structures. We noted that hippocampal volumes in our sample were significantly smaller in cases than in controls (ANOVA P=3E-06) [32] [33] [34] , and there were also significant reductions in cases for the amygdala volumes (P=0.001), but not for the caudate. Gaser et al. reported ventricular enlargement in schizophrenia associated with volumetric reduction of the thalamus and superior temporal cortex [30] ; in our data, however, we did not observe significant correlation between the volumes of these structures and the volume of the temporal horn of lateral ventricle, or any detectable associations between these structures volumes and the CSF volume-associated genes.
In our analyses we observed significantly larger volumes of the temporal horn of left lateral ventricle in cases vs. controls, and polymorphism in the Neurexin1 gene (NRXN1) was associated with this endophenotype. When we combined temporal horns values across hemispheres, the association was still suggestively significant (P=4.92E-10). The Psychiatric Genomic Consortium (PGC) reported an association P= 0.005685 for this same SNP marker of NRXN1 (rs80262609) with diagnosis in their large case-control schizophrenia GWAS [1] . Structural variants (CNVs) disrupting this gene have been associated with a wide spectrum of brain disorders including schizophrenia [20, 35, 36] , and with cognitive performance through the regulation of post-synaptic N-methyl d-aspartate receptors [37] . This gene is expressed in the adult brain [38] , and during development in the fetal brain [39] .
The cavum septum pellucidum is a space between the two leaflets of the septum pellucidum that normally occludes in 85% of babies by age 6 months [40] ; its persistence has been related to neurodevelopmental delay [41] , and with SZ and BD [17, 18, 42, 43] , presumably because of a reduction of the limbic structures that surround it: the septal nuclei, fornix and hippocampal commissure. In our sample this quantitative phenotype measured in voxels by FreeSurfer was significantly different in cases vs. controls (ANOVA P=9.4E-05, Figure 2) , with larger volumes for individuals with SZ than BP, which is consistent with findings from Shioiri et al. [18] . One of the genes identified in association with the CSP volume, the LDL receptor related protein 1B, has been associated with Attention Deficit/Hyperactivity Disorder and Alzheimer's disease [22, 44] . LRP1B is reported expressed in the adult and fetal brain [45] which, along with its association with an anatomical quantitative trait (CSP) of a persistent fetal structure, supports a role of this gene in a neurodevelopmental hypothesis of Bipolar Disorder and Schizophrenia [26] . RORA is a nuclear receptor that participates in the transcriptional regulation of some genes involved in circadian rhythm and in the response to lithium treatment in bipolar disorder [46] . In mice, RORα is essential for development of cerebellum through direct regulation of genes expressed in Purkinje cells.
According to UK Brain Expression Consortium (UKBEC) eQTL data (http://www.braineac.org/), rs80262609 is an eQTL SNP (P < 0.01) for NRXN1 in putamen area, temporal cortex, frontal cortex, and thalamus ( Supplementary Table 3 ), whereas rs6494245 is primarily an eQTL SNP for VPS13C in hippocampus, cerebellum, and occipital cortex; also associated with expression of RORA in hippocampus, frontal cortex, medulla, and thalamus; associated with NARG2 expression in hippocampus, cerebellum, and frontal cortex; with ANXA2 expression in hippocampus. Among these genes, RORA is a core transcription factor involving circadian rhythms. VPS13C involves mitochondrial function and maintenance of mitochondrial transmembrane potential. NARG2 regulates small nuclear RNA (snRNA) gene transcription. ANXA2 involves in exocytosis. Co-expression analysis of NRXN1 and LRP1B using the Neuropsychiatric Disorder De Novo Mutations Database [47] identified genes involved in cell adhesion (including Cadherin13) and neurotransmission (including the Glutamate Ionotropic Receptor AMPA 2 ( Supplementary Figure 3) . Previously published B-SNIP analyses on a subset of this sample looking for gene networks associated with some of these phenotypes found cell adhesion networks containing CDH13, NRXN3 and RORA in association with EEG oscillations, event-related potentials, resting state fMRI and structural MRI phenotypes [12, [48] [49] [50] [51] . Although not a replication because our data contains that subsample, this study may represent support for these previous studies with respect to CDH13 and RORA.
The significant genetic associations with volumes of the temporal horn of lateral ventricle and of the CSP represent novel genetic findings on the molecular basis of psychotic disorders, and are the first genetic associations with psychosis that pinpoint a stage of brain development by direct anatomic observation. The relationship between age of onset of psychosis and a ventricular volume, in the context of a significant genetic association for one of the two phenotypes and a suggestive association for the other, is the type of finding that gives credence to the B-SNIP consortium deep phenotyping approach study [2] . We have observed highly significant p-values with a relatively smaller sample size than needed for disease association, and relatively large effect sizes for the significant associations, which suggest that diagnosis may be a more difficult phenotype to study than some of its observable components.
Genotype Imputation: After QC, PsychChip genotypes were imputed to the 1000 Genomes project multiethnic reference panel [58] using HAPI-UR for pre-phasing and IMPUTE2 [59] [60] [61] . Chromosomes were phased separately, and then divided into 5 megabase pair chunks for imputation. Poorly imputed single nucleotide polymorphisms (SNPs) were filtered post-imputation. The final imputed genotype set contained more than 30 Million autosomal markers, reduced to 4,322,238 variants after filtering for 0.05 missingness by marker, 0.02 missingness by individual sample and MAF 0.05, to work with common variants.
GWAS analysis: were performed using PLINK 1.9 [62, 63] on the Bionimbus protected cloud of the Open Science Data Cloud servers at the University of Chicago [64] (http://www.opensciencedatacloud.org). Genetic locations refer to the human genome GRCh37/hg19 build, gene mapping was done using the UCSC genome browser [65] , and graphics generated with Manhattan Plotter [66] and LocusZoom [67] . Population stratification was expected in the B-SNIP1 sample, as it contains people from diverse ethnicities. We ran Principal Component Analysis (PCA) on the genotypes to examine population stratification and admixture in our sample ( Supplementary Figure 1a) . Then, the first two PCA eigenvectors which captured the vast majority of the ethnic-related variance ( Supplementary Figure 1b) were used as covariates in the GWAS regression model to correct for population stratification and admixture [68] . Sex was also used as a covariate in all our analyses. Although recent publications use multiple additional covariates (like case-control status, age, total intracranial volume, etc.) [16, 69] , in our study we explicitly avoided them because correcting for factors that are related to the disease could diminish the possibility of detecting associations with loci that differentiate cases and controls, or that are related to the evolution of the disease and that can thus be responsible for phenotypic variance. Where significant or suggestive gene associations were observed with a phenotype, analysis of variance (ANOVA) was used to test for significant case-control phenotypic differences, calculated with IBM SPSS Statistics version 24. Q-Q plots were used to examine possible inflation in GWAS results (Suppl. Figure  2 ).
Significance Thresholds:
The classic definition of statistically suggestive and significant probability thresholds in whole genome analysis is that a result is suggestive if it is expected to occur not more than once in a single genome-wide analysis, and significant if it is expected to occur not more than once in the context of all the analyses under consideration [70] . The GWAS statistical significance threshold for a single phenotype analysis of imputed data using the 1000 Genomes reference panel is accepted as P < 1E-08, based on the number of effective markers (Li et al. [71] ). In the context of the multiple analyses reported here, this would be our threshold for suggestive significance. Given the different classes of phenotype classes analyzed (psychiatric scales, clinical data, fractional anisotropy and structural MRI, we opted for a Family-Wise Error Rate (FWER) approach (considering each class of variable as a separate family) to correct for multiple testing and declare FWER significance (Supplementary Table 1 ). We note separately findings that pass a Bonferroni correction for all variables analyzed. 
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Figure 2: Cavum Septum Pellucidum volume distribution in Cases and Controls
The distribution of CSP volumes (in Voxels) in cases and controls by diagnostic categories identified significant differences between groups (ANOVA P=9.4E-05). 
